Skip to search formSkip to main contentSkip to account menu

Bcl-2 Inhibitor BCL201

Known as: BCL-201, BCL201 
A selective inhibitor of the anti-apoptotic protein B-cell lymphoma 2 (Bcl-2), with potential pro-apoptotic and antineoplastic activities. Upon… 
National Institutes of Health

Related topics

Related topics

2 relations

Narrower (2)

S-55746Servier 1

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Abstract 381: Combined inhibition of Bcl-2 and MCL-1 in small cell lung cancer (SCLC) is most effective in tumors with low Bcl-xL expression
Introduction: SCLC is an aggressive high-grade neuroendocrine malignancy in which targeting anti-apoptotic regulators such as Bcl… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)